The Scientist

» opinion and disease/medicine

Most Recent

image: Opinion: Token Pharmacovigilance

Opinion: Token Pharmacovigilance

By | May 23, 2017

A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?

2 Comments

image: Opinion: The Frustrating Process of Manuscript Submission

Opinion: The Frustrating Process of Manuscript Submission

By and | May 10, 2017

We suggest a centralized facility for submitting to journals—one that would benefit scientists and not only publishers.

3 Comments

image: Opinion: Get to Know Why People Openly Share Genomic Data

Opinion: Get to Know Why People Openly Share Genomic Data

By | May 9, 2017

It’s not only about health but also about exploring ancestry and contributing to science.

0 Comments

image: Opinion: When Science Meets Activism

Opinion: When Science Meets Activism

By | May 3, 2017

Scientists new to advocacy must find balance between embracing diverse perspectives and guarding against anti-scientific beliefs.

3 Comments

image: Quick and Cheap Zika Detection

Quick and Cheap Zika Detection

By | May 3, 2017

A heat block, a truck battery, and a novel RNA amplification assay make for in-the-field surveillance of the virus.

0 Comments

Studies of infected rhesus monkeys reveal the virus’s long-term hiding places in the body.

1 Comment

image: Contributors

Contributors

By | April 1, 2017

Meet some of the people featured in the April 2017 issue of The Scientist.

0 Comments

image: Hitting It Out of the Park

Hitting It Out of the Park

By | April 1, 2017

Cancer can be as evasive and slippery as a spitball, but new immunotherapies are starting to connect.

0 Comments

image: Location, Location, Location

Location, Location, Location

By | April 1, 2017

Since first proposing that a cell’s function and biology depend on its surroundings, Mina Bissell continues to probe the role of the extracellular matrix.

2 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

Popular Now

  1. A Coral to Outlast Climate Change
  2. Antarctica Is Turning Green
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. How to Tell a Person’s “Brain Age”
AAAS